The FDA's approval of colchicine, which is marketed and sold under the name Lodoco, is expected to have a big impact on cardiac care and outcomes.

The new company formed in 2021, but waited until now to publicly launch. Its founders included two Stanford University physicians.

The FDA has labeled this as a Class I recall, which means using these devices can lead to significant injuries, including death.

A new systematic review and meta-analysis of 30 RCTs highlighted numerous benefits associated with vegetarian and vegan diets. Combining a plant-based diet with statin therapy, one researcher noted, could result "in an even larger beneficial effect.”

The new analysis, published in JAMA, suggests that CT results can help identify medium- and high-risk patients who may need to be considered for statin therapy or other preventive treatments.

The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.

When PCI-capable hospitals open and close, how does it impact patient care for the surrounding area? Researchers aimed to find out, sharing their findings in JACC: Cardiovascular Interventions.

The healthcare technology company, previously known as Angel Medical Systems, is merging with BIOS Acquisition Corporation to form a new publicly traded company.